Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Oxford Immunotec GlobalMeridian BioscienceHeskaQuotient
SymbolNASDAQ:OXFDNASDAQ:VIVONASDAQ:HSKANASDAQ:QTNT
Price Information
Current Price$15.69$9.91$73.92$7.63
52 Week RangeBuyHoldHoldBuy
Analyst Ratings
Consensus RecommendationBuyHoldHoldBuy
Consensus Price Target$20.00$11.33$76.67$13.50
% Upside from Price Target27.47% upside14.36% upside3.72% upside76.93% upside
Trade Information
Market Cap$409.97 million$382.27 million$568.92 million$487.08 million
Beta0.430.381.040.99
Average Volume255,835304,967102,425259,431
Sales & Book Value
Annual Revenue$59.75 million$213.57 million$127.45 million$29.13 million
Price / Sales7.051.984.5217.36
Cashflow$0.69 per share$1.05 per share$2.10 per shareN/A
Price / Cash22.859.4035.14N/A
Book Value$8.12 per share$4.14 per share$16.13 per share$0.03 per share
Price / Book1.932.394.58254.33
Profitability
Net Income$120.78 million$23.84 million$5.85 million$-105,390,000.00
EPS$0.51$0.74$1.42($1.92)
Trailing P/E Ratio30.7613.3952.06N/A
Forward P/E RatioN/A19.43616.00N/A
P/E GrowthN/AN/AN/AN/A
Net Margins208.48%12.65%1.93%-352.75%
Return on Equity (ROE)14.76%17.82%6.35%N/A
Return on Assets (ROA)12.58%11.97%4.85%-57.94%
Dividend
Annual PayoutN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/A
Three-Year Dividend GrowthN/A-14.50%N/AN/A
Payout RatioN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%0.40%0.04%72.27%
Current Ratio13.35%6.93%3.93%5.17%
Quick Ratio12.76%4.75%2.05%4.42%
Ownership Information
Institutional Ownership Percentage94.09%88.58%89.08%70.56%
Insider Ownership Percentage4.21%2.00%14.00%14.20%
Miscellaneous
Employees215585347N/A
Shares Outstanding26.83 million42.71 million7.80 million66.27 million
Next Earnings Date11/8/2019 (Estimated)11/14/2019 (Estimated)11/5/2019 (Estimated)11/4/2019 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionable
 Oxford Immunotec GlobalMeridian BioscienceHeskaQuotient

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel